Organigram Holdings | OGI - Interest Expense On Debt


Organigram Holdings reported CAD179K in Interest Expense on Debt for its fiscal quarter ending in March of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 349.66M 12.86M Jun/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Aurora Cannabis CAD 230K 1.88M Mar/2026
Avita Medical AUD 1.25M 100K Jun/2025
Canopy Growth CAD 12.31M 4.97M Mar/2026
Cronos Group USD 0 7K Sep/2024
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 1000K Jun/2026
IQVIA Holdings USD 197M 5M Jun/2026
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Moderna USD 10.96B 527M Jun/2026
Organigram Holdings CAD 179K 127K Mar/2025
Organon & Co USD 108M 3M Jun/2026
Revvity USD 22.99M 1.73M Jun/2026
Tectonic Therapeutic USD 246.58M 246.56M Mar/2026
Tilray USD 6.7M 2.73M Jun/2025
Viatris USD 120.7M 600K Jun/2026
Xeris Pharmaceuticals USD 6.88M 269K Mar/2026